ThaiFDA Hosts International Health, Wellness and Longevity Innovation Forum 2026

Key summary

The Thai Food and Drug Administration (FDA) concluded the 'ThaiFDA International Health, Wellness and Longevity Innovation Forum 2026' (ThaiFDA WELLNEXT 2026), held from October 23 to 25, 2026, at Royal Paragon Hall, Siam Paragon. The event, themed 'From Thai Innovation to Global Trust,' attracted over 14,000 attendees including entrepreneurs, experts, researchers, investors, and the public. Dr. Suchapa Boonsri, FDA Commissioner, emphasized fostering global trust through Thai innovation while maintaining safety standards. The forum featured 165 exhibitors presenting 123 health products, technologies, services, and innovations. Key activities included a Next Connect program facilitating 150 business matching sessions and FDA Consultation Clinic appointments with support from 10 partner agencies covering product development, regulatory approval, intellectual property, funding, and market expansion. Educational exchanges occurred through International Symposiums, WELLNEXT Stage, and Mini Stage sessions featuring over 30 topics presented by 49 experts on longevity science, medical technology, and health economics. The event also hosted a WELLNEXT Pitching Challenge with categories for Market Pitching and Future Pitching. Winners included Plant Origin Food Co., Ltd. (chaff-based protein), InnoFalcon (Tycos-1 muscle pain relief cream), Skinscape (multi-omics skin analysis), CheeCare (urine-to-health-data innovation), Hippocrates AI (AccuLiver AI liver volume assessment), and Hibiscus Film (pH testing film). The FDA plans to utilize event feedback to support continuous product development and market access for Thai health innovations.